You are here

COPD

AstraZeneca’s Fasenra asthma drug shows promise for COPD treatment

Biopharma Reporter

Tue, 05/21/24 - 11:27 am

clinical trials

Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD

Fierce Pharma

Mon, 05/20/24 - 11:25 am

Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential

Fierce Biotech

Wed, 05/15/24 - 11:21 am

Blackstone Life Sciences

Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch

BioSpace

Fri, 05/10/24 - 11:28 am

Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024

BioSpace

Wed, 05/1/24 - 09:31 am

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024

BioSpace

Wed, 03/27/24 - 11:06 am

After decades of waiting, late-stage therapies may penetrate the COPD market this year

Clinical Trials Arena

Sun, 03/24/24 - 10:31 pm

drug development

GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month

Fierce Pharma

Thu, 03/21/24 - 06:37 pm

Boehringer Ingelheim

AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers

Reuters

Mon, 03/18/24 - 11:05 am

Boehringer Ingelheim

Bevespi Aerosphere

Breztri Aerosphere

AstraZeneca kick-starts Phase III COPD trial for Breztri

Clinical Trials Arena

Thu, 03/14/24 - 11:21 am

clinical trials

Boehringer to cap out-of-pocket inhaler cost at $35 per month

Reuters

Thu, 03/7/24 - 11:08 am

Boehringer Ingelheim

Combivent Respimat

Spiriva HandiHale

Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD

BioSpace

Fri, 02/23/24 - 10:43 am

priority review

4 biotechs to watch in 2024

Pharma Voice

Wed, 02/21/24 - 11:28 am

Alto Neuroscience

Karuna Therapeutics

Madrigal Pharmaceuticals

precision medicine

Alzheimer's disease

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva

Fierce Pharma

Sun, 01/7/24 - 04:07 pm

Boehringer Ingelheim

Verona Gets $400M Boost from Oxford Finance, Hercules Capital for COPD Candidate

BioSpace

Wed, 01/3/24 - 09:51 am

Sanofi, Regeneron eye Dupixent label expansion with promising COPD data

Medical Marketing and Media

Tue, 11/28/23 - 10:27 am

clinical trials

Viatris and Theravance report data from COPD treatment trial

Clinical Trials Arena

Tue, 11/14/23 - 09:24 am

clinical trials

Samay’s AI-enabled wearable ‘can diagnose COPD’

Pharmaphorum

Thu, 11/2/23 - 11:38 am

artificial intelligence

FDA warns AstraZeneca over false advertising of COPD drug

Beckers Hospital Review

Thu, 08/17/23 - 09:52 am

Breztri Aerosphere

DTC advertising

Sanofi, Regeneron flesh out COPD data with Dupixent

Pharmaphorum

Mon, 05/22/23 - 10:16 am

Pages